110 related articles for article (PubMed ID: 2682137)
1. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats.
Kraegen EW; James DE; Jenkins AB; Chisholm DJ; Storlien LH
Metabolism; 1989 Nov; 38(11):1089-93. PubMed ID: 2682137
[TBL] [Abstract][Full Text] [Related]
2. The effect of the new oral hypoglycemic agent A-4166 on glucose turnover in the high fat diet-induced and/or in the hereditary insulin resistance of rats.
Klimes I; Mitková A; Gasperíková D; Ukropec J; Líska B; Bohov P; Stanek J; Seböková E
Arch Physiol Biochem; 1998 Oct; 106(4):325-32. PubMed ID: 10417860
[TBL] [Abstract][Full Text] [Related]
3. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration.
Kraegen EW; James DE; Storlien LH; Burleigh KM; Chisholm DJ
Diabetologia; 1986 Mar; 29(3):192-8. PubMed ID: 3516775
[TBL] [Abstract][Full Text] [Related]
4. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects.
Shargill NS; Tatoyan A; Fukushima M; Antwi D; Bray GA; Chan TM
Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364
[TBL] [Abstract][Full Text] [Related]
5. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
6. Chronic exercise compensates for insulin resistance induced by a high-fat diet in rats.
Kraegen EW; Storlien LH; Jenkins AB; James DE
Am J Physiol; 1989 Feb; 256(2 Pt 1):E242-9. PubMed ID: 2645785
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
8. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats.
Storlien LH; James DE; Burleigh KM; Chisholm DJ; Kraegen EW
Am J Physiol; 1986 Nov; 251(5 Pt 1):E576-83. PubMed ID: 3535532
[TBL] [Abstract][Full Text] [Related]
9. Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats.
Storlien LH; Thorburn AW; Smythe GA; Jenkins AB; Chisholm DJ; Kraegen EW
Diabetes; 1989 Apr; 38(4):499-503. PubMed ID: 2647557
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of insulin action in muscle: influence of blood flow.
James DE; Burleigh KM; Storlien LH; Bennett SP; Kraegen EW
Am J Physiol; 1986 Oct; 251(4 Pt 1):E422-30. PubMed ID: 3532818
[TBL] [Abstract][Full Text] [Related]
11. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
12. Time dependence of insulin action in muscle and adipose tissue in the rat in vivo. An increasing response in adipose tissue with time.
James DE; Burleigh KM; Kraegen EW
Diabetes; 1985 Oct; 34(10):1049-54. PubMed ID: 3899807
[TBL] [Abstract][Full Text] [Related]
13. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
[TBL] [Abstract][Full Text] [Related]
14. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats.
Kraegen EW; Clark PW; Jenkins AB; Daley EA; Chisholm DJ; Storlien LH
Diabetes; 1991 Nov; 40(11):1397-403. PubMed ID: 1936601
[TBL] [Abstract][Full Text] [Related]
15. The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
Stevenson RW; McPherson RK; Persson LM; Genereux PE; Swick AG; Spitzer J; Herbst JJ; Andrews KM; Kreutter DK; Gibbs EM
Diabetes; 1996 Jan; 45(1):60-6. PubMed ID: 8522061
[TBL] [Abstract][Full Text] [Related]
16. Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo.
Ng SF; Storlien LH; Kraegen EW; Stuart MC; Chapman GE; Lazarus L
Metabolism; 1990 Mar; 39(3):264-8. PubMed ID: 2407927
[TBL] [Abstract][Full Text] [Related]
17. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
Weinstein SP; Holand A; O'Boyle E; Haber RS
Metabolism; 1993 Oct; 42(10):1365-9. PubMed ID: 8412752
[TBL] [Abstract][Full Text] [Related]
18. Microdialysis and 2-[18F]fluoro-2-deoxy-D-glucose (FDG): a study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue.
Haaparanta M; Paul R; Grönroos T; Bergman J; Kämäräinen EL; Solin O
Life Sci; 2003 Aug; 73(11):1437-51. PubMed ID: 12850504
[TBL] [Abstract][Full Text] [Related]
19. The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity.
Henriksen EJ; Teachey MK; Lindborg KA; Diehl CJ; Beneze AN
Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1813-21. PubMed ID: 18385470
[TBL] [Abstract][Full Text] [Related]
20. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice.
Colca JR; Wyse BM; Sawada G; Jodelis KS; Connell CL; Fletcher-McGruder BL; Palazuk BJ; Diani AR
Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
